CD93 and neoplasm: Analysis of HCmel12 tumors injected subcutaneously in CD93–/iECKO mice showed a trend toward decreased tumor growth compared with the control group; however, statistical significance was not reached, likely due to variation in CD93 expression in CD93–/iECKO mice (Figure 4C).